deltatrials
Recruiting PHASE2 INTERVENTIONAL 3-arm NCT02960022

A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

A Phase 2 Open-label Extension Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

Sponsor: Astellas Pharma Global Development, Inc.

Conditions Prostate Cancer
Interventions Leuprolide acetate abiraterone acetate enzalutamide prednisone
Updated 60 times since 2017 Last updated: Dec 16, 2025 Started: Dec 22, 2016 Primary completion: Jul 31, 2029 Completion: Jul 31, 2029
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Prostate Cancer and is currently actively recruiting participants. Astellas Pharma Global Development, Inc. leads this study, which shows 60 recorded versions since 2016 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Mar 2017 · 28 days · monthly snapshot~Mar 2017 – ~Jun 2017 · 3 months · monthly snapshot~Jun 2017 – ~Jul 2017 · 30 days · monthly snapshot~Jul 2017 – ~Oct 2017 · 3 months · monthly snapshot~Oct 2017 – ~Apr 2018 · 6 months · monthly snapshot~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshot~Jun 2018 – ~Feb 2019 · 8 months · monthly snapshot~Feb 2019 – ~May 2019 · 3 months · monthly snapshot~May 2019 – ~Dec 2019 · 7 months · monthly snapshot~Dec 2019 – ~Apr 2020 · 4 months · monthly snapshot~Apr 2020 – ~May 2020 · 30 days · monthly snapshot~May 2020 – ~Jun 2020 · 31 days · monthly snapshot~Jun 2020 – ~Aug 2020 · 2 months · monthly snapshot~Aug 2020 – ~Oct 2020 · 2 months · monthly snapshot~Oct 2020 – ~Nov 2020 · 31 days · monthly snapshot~Nov 2020 – ~Dec 2020 · 30 days · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshot~Apr 2021 – ~May 2021 · 30 days · monthly snapshot~May 2021 – ~Sep 2021 · 4 months · monthly snapshot~Sep 2021 – ~Oct 2021 · 30 days · monthly snapshot~Oct 2021 – ~Nov 2021 · 31 days · monthly snapshot~Nov 2021 – ~Jan 2022 · 2 months · monthly snapshot~Jan 2022 – ~Mar 2022 · 59 days · monthly snapshot~Mar 2022 – ~Apr 2022 · 31 days · monthly snapshot~Apr 2022 – ~Jun 2022 · 2 months · monthly snapshot~Jun 2022 – ~Jul 2022 · 30 days · monthly snapshot~Jul 2022 – ~Sep 2022 · 2 months · monthly snapshot~Sep 2022 – ~Oct 2022 · 30 days · monthly snapshot~Oct 2022 – ~Jan 2023 · 3 months · monthly snapshot~Jan 2023 – ~Mar 2023 · 59 days · monthly snapshot~Mar 2023 – ~Apr 2023 · 31 days · monthly snapshot~Apr 2023 – ~May 2023 · 30 days · monthly snapshot~May 2023 – ~Jun 2023 · 31 days · monthly snapshot~Jun 2023 – ~Jul 2023 · 30 days · monthly snapshot~Jul 2023 – ~Aug 2023 · 31 days · monthly snapshot~Aug 2023 – ~Sep 2023 · 31 days · monthly snapshot~Sep 2023 – ~Oct 2023 · 30 days · monthly snapshot~Oct 2023 – ~Nov 2023 · 31 days · monthly snapshot~Nov 2023 – ~Dec 2023 · 30 days · monthly snapshot~Dec 2023 – ~Jan 2024 · 31 days · monthly snapshot~Jan 2024 – ~Feb 2024 · 31 days · monthly snapshot~Feb 2024 – ~Apr 2024 · 2 months · monthly snapshot~Apr 2024 – ~Jun 2024 · 2 months · monthly snapshot~Jun 2024 – ~Jul 2024 · 30 days · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Oct 2024 · 30 days · monthly snapshot~Oct 2024 – ~Nov 2024 · 31 days · monthly snapshot~Nov 2024 – ~Dec 2024 · 30 days · monthly snapshot~Dec 2024 – ~Jan 2025 · 31 days · monthly snapshot~Jan 2025 – ~Mar 2025 · 59 days · monthly snapshot~Mar 2025 – ~Apr 2025 · 31 days · monthly snapshot~Apr 2025 – ~May 2025 · 30 days · monthly snapshot~May 2025 – ~Jun 2025 · 31 days · monthly snapshot~Jun 2025 – ~Sep 2025 · 3 months · monthly snapshot~Sep 2025 – ~Oct 2025 · 30 days · monthly snapshot~Oct 2025 – ~Dec 2025 · 2 months · monthly snapshot~Dec 2025 – ~Jan 2026 · 31 days · monthly snapshot~Jan 2026 – present · 8 months · monthly snapshot

Change History

60 versions recorded

  1. Jan 2026 — Present [monthly]

    Recruiting PHASE2

  2. Dec 2025 — Jan 2026 [monthly]

    Recruiting PHASE2

  3. Oct 2025 — Dec 2025 [monthly]

    Recruiting PHASE2

  4. Sep 2025 — Oct 2025 [monthly]

    Recruiting PHASE2

  5. Jun 2025 — Sep 2025 [monthly]

    Recruiting PHASE2

▶ Show 55 earlier versions

  1. May 2025 — Jun 2025 [monthly]

    Recruiting PHASE2

  2. Apr 2025 — May 2025 [monthly]

    Recruiting PHASE2

  3. Mar 2025 — Apr 2025 [monthly]

    Recruiting PHASE2

  4. Jan 2025 — Mar 2025 [monthly]

    Recruiting PHASE2

  5. Dec 2024 — Jan 2025 [monthly]

    Recruiting PHASE2

  6. Nov 2024 — Dec 2024 [monthly]

    Recruiting PHASE2

  7. Oct 2024 — Nov 2024 [monthly]

    Recruiting PHASE2

  8. Sep 2024 — Oct 2024 [monthly]

    Recruiting PHASE2

  9. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE2

  10. Jun 2024 — Jul 2024 [monthly]

    Recruiting PHASE2

  11. Apr 2024 — Jun 2024 [monthly]

    Recruiting PHASE2

  12. Feb 2024 — Apr 2024 [monthly]

    Recruiting PHASE2

  13. Jan 2024 — Feb 2024 [monthly]

    Recruiting PHASE2

  14. Dec 2023 — Jan 2024 [monthly]

    Recruiting PHASE2

  15. Nov 2023 — Dec 2023 [monthly]

    Recruiting PHASE2

  16. Oct 2023 — Nov 2023 [monthly]

    Recruiting PHASE2

  17. Sep 2023 — Oct 2023 [monthly]

    Recruiting PHASE2

  18. Aug 2023 — Sep 2023 [monthly]

    Recruiting PHASE2

  19. Jul 2023 — Aug 2023 [monthly]

    Recruiting PHASE2

  20. Jun 2023 — Jul 2023 [monthly]

    Recruiting PHASE2

  21. May 2023 — Jun 2023 [monthly]

    Recruiting PHASE2

  22. Apr 2023 — May 2023 [monthly]

    Recruiting PHASE2

  23. Mar 2023 — Apr 2023 [monthly]

    Recruiting PHASE2

  24. Jan 2023 — Mar 2023 [monthly]

    Recruiting PHASE2

  25. Oct 2022 — Jan 2023 [monthly]

    Recruiting PHASE2

  26. Sep 2022 — Oct 2022 [monthly]

    Recruiting PHASE2

  27. Jul 2022 — Sep 2022 [monthly]

    Recruiting PHASE2

  28. Jun 2022 — Jul 2022 [monthly]

    Recruiting PHASE2

  29. Apr 2022 — Jun 2022 [monthly]

    Recruiting PHASE2

  30. Mar 2022 — Apr 2022 [monthly]

    Recruiting PHASE2

  31. Jan 2022 — Mar 2022 [monthly]

    Recruiting PHASE2

  32. Nov 2021 — Jan 2022 [monthly]

    Recruiting PHASE2

  33. Oct 2021 — Nov 2021 [monthly]

    Recruiting PHASE2

  34. Sep 2021 — Oct 2021 [monthly]

    Recruiting PHASE2

  35. May 2021 — Sep 2021 [monthly]

    Recruiting PHASE2

  36. Apr 2021 — May 2021 [monthly]

    Recruiting PHASE2

  37. Jan 2021 — Apr 2021 [monthly]

    Recruiting PHASE2

  38. Dec 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

  39. Nov 2020 — Dec 2020 [monthly]

    Recruiting PHASE2

  40. Oct 2020 — Nov 2020 [monthly]

    Recruiting PHASE2

  41. Aug 2020 — Oct 2020 [monthly]

    Recruiting PHASE2

  42. Jun 2020 — Aug 2020 [monthly]

    Recruiting PHASE2

  43. May 2020 — Jun 2020 [monthly]

    Recruiting PHASE2

  44. Apr 2020 — May 2020 [monthly]

    Recruiting PHASE2

  45. Dec 2019 — Apr 2020 [monthly]

    Recruiting PHASE2

  46. May 2019 — Dec 2019 [monthly]

    Recruiting PHASE2

  47. Feb 2019 — May 2019 [monthly]

    Recruiting PHASE2

  48. Jun 2018 — Feb 2019 [monthly]

    Recruiting PHASE2

  49. Apr 2018 — Jun 2018 [monthly]

    Recruiting PHASE2

  50. Oct 2017 — Apr 2018 [monthly]

    Recruiting PHASE2

  51. Jul 2017 — Oct 2017 [monthly]

    Recruiting PHASE2

  52. Jun 2017 — Jul 2017 [monthly]

    Recruiting PHASE2

  53. Mar 2017 — Jun 2017 [monthly]

    Recruiting PHASE2

    Status: Approved For Marketing → Recruiting · Phase: NA → PHASE2

  54. Feb 2017 — Mar 2017 [monthly]

    Approved For Marketing NA

  55. Jan 2017 — Feb 2017 [monthly]

    Approved For Marketing NA

    First recorded

Dec 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Astellas Pharma Global Development, Inc.
  • Pfizer
Data source: Astellas Pharma Inc

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aalborg, Denmark , Aarhus, Denmark , Abbotsford, Canada , Albury, Australia , Amsterdam, Netherlands , Anchorage, United States , Anderlecht, Belgium , Arezzo, Italy , Ashford, Australia , Auckland, New Zealand and 195 more locations